Paul Jedlicka - Concepedia

Author

Paul Jedlicka

Also Known As

J PAUL, J Paul, Jedlicka Paul, Joanne Masterson, P JEDLICKA, P Jedlicka, P. Jedlicka, Paul Jedlicka, Paul Jedlicka (407731)

190

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver University of Colorado Anschutz Medical Campus Children's Hospital Colorado University of Colorado Cancer Center University of California San Diego

About

Paul Jedlicka is an author at University of Colorado Denver specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	2K
2	Cell Biology	18	19	1.6K
3	Natural Sciences	3	3	161
4	Health Sciences	1	1	118
5	Cellular Physiology	1	1	61

Paul Jedlicka

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa Eric T. Clambey, Eóin N. McNamee, Joseph A. Westrich, Proceedings of the National Academy of Sciences	2012	539
Transmigrating Neutrophils Shape the Mucosal Microenvironment through Localized Oxygen Depletion to Influence Resolution of Inflammation Eric L. Campbell, Walter J. Bruyninckx, Caleb Kelly, Immunity	2014	444
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Dawn R. Cochrane, Sebastián Bernales, Britta M. Jacobsen, Breast Cancer Research	2014	391
Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome Viola Neudecker, Moritz Haneklaus, Owen Jensen, The Journal of Experimental Medicine	2017	355
Interleukin 37 expression protects mice from colitis Eóin N. McNamee, Joanne C. Masterson, Paul Jedlicka, Proceedings of the National Academy of Sciences	2011	316
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling Douglas S. Micalizzi, Kimberly Christensen, Paul Jedlicka, Journal of Clinical Investigation	2009	231
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings, Oncogene OncologyMedicineReceptor Tyrosine KinaseCell DeathBronchial Neoplasm	2012	215
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide <i>In Vivo</i> Valerie N. Barton, Nicholas C. D’Amato, Melita A. Gordon, Molecular Cancer Therapeutics Androgen ReceptorBreast OncologyCancer BiologyTumor BiologyOncology	2015	211
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition Erica McCoy, Ritsuko Iwanaga, Paul Jedlicka, Journal of Clinical Investigation	2009	171
Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis Louise Glover, Brittelle Bowers, Bejan Saeedi, Proceedings of the National Academy of Sciences	2013	150

Page 1